The cost associated with administering risperidone long-acting injections in the Australian community

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Dalton, Andrew ^a   Lambert, Tim ^b   Schrover, Rudolf ^c   Hertel, Judy ^c   Smith, Dell ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; COST CONTROL; CROSS-SECTIONAL STUDY; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRALIA; COST SAVINGS; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80053341324     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-236     Document Type: Article

References (11)

1. National Mental Health Report 2010: Summary of 15 Years of reform in Australia's Mental Health Services under the National Mental Health Strategy 1993-2008. Department of Health and Ageing, Canberra: Commonwealth of Australia 2010
2. Mental health services in Australia 2007-08. Mental health series no. 12. Cat. no. HSE 88. Australian Institute of Health and Welfare, Canberra: AIHW 2010
3. A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia. Pandina G, Lane R, Gopal S, Gassmann-Mayer C, Hough D, Remmerie B, Simpson G, Prog Neuropsychopharmacol Biol Psychiatry 2011 35 1 218 226 10.1016/j.pnpbp.2010.11.008 21092748
4. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study. Carr VJ, Neil AL, Halpin SA, Holmes S, Lewin TJ, Aust N Z J Psychiatry 2003 37 1 31 40 10.1046/j.1440-1614.2003.01092.x 12534654 (Pubitemid 36395326)
5. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics. Fitzgerald PB, Montgomery W, de Castella AR, Filia KM, Filia SL, Christova L, Jackson D, Kulkarni J, Aust N Z J Psychiatry 2007 41 10 819 829 10.1080/00048670701579025 17828655 (Pubitemid 47399960)
6. National hospital cost data collection. Cost report round 12 (2007-2008). Public Hospitals: A-DRG 5.1; Private Hospitals AR-DRG 5.1; Private Day Hospital Facilities: AR-DRG 5.1. Commonwealth Department of Health and Ageing in conjuction with state/territory health departments public and private hospitals and private day hospital facilities, Canberra: Commonwealth of Australia 2009 http://www.health.gov.au/internet/main/publishing.nsf/Content/ 0BF59B7DB88A427FCA257609001FCD3D/$File/1-R12CostReport.pdf (accessed 12 October 2010).
7. Medical benefits schedule. Australian Government Department of Health and Aging, 2010 http://www9.health.gov.au/mbs/search.cfm?pdf=yes
8. Remuneration Tribunal: Determination 2004/03: Official travel by officer holders. Australian Government Remuneration Tribunal, 2010 http://www. remtribunal.gov.au/conditions/officialtravel/default.asp
9. Australian Bureau of Statistics: 1216.0-Australian Standard Geographical Classification (ASGC). Canberra: Commonwealth of Australia 2009
10. IMS National sales data for Risperidone Consta. Janssen-Cilag Pty Ltd 2009 Data on file
11. COAG national action plan on mental health (2006-2011). Mental Health, http://www.health.gov.au/internet/main/publishing.nsf/Content/mental-coag accessed 20 October